During the past decade, Nzoz Salus conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nzoz Salus" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Nzoz Salus" are "Heart Failure" (3 trials). Many other conditions were trialed in "Nzoz Salus" in a lesser frequency.

Most popular intervention types in "Nzoz Salus" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Empagliflozin" (2 trials) and "Neladenoson bialanate (BAY1067197)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nzoz Salus" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Nzoz Salus". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Nzoz Salus, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Nzoz Salus, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".